FDA Creating New Investment Opportunities in BioTech Stocks
Because FDA marketing clearance to sell a drug or device in the US remains the brass ring for medical manufacturers [...]
SanaCurrents Introduction – Turn to the Biotech Experts to Maximize Your Returns
Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious and sophisticated biotech investor. Founder of SanaCurrents, Bill Langbein, finally [...]
Welcome to SanaCurrents
Life science investing always has been a roller coaster ride, as well as a minefield, usually with more deep dips [...]
Sinovac Biotech: Court Documents Show CEO Bribed Chinese FDA, Buyout Offers Could Be in Jeopardy
Summary Recently disclosed court documents show that Sinovac Biotech’s (NASDAQ: SVA) CEO bribed a member of the Chinese Food and [...]
Repro Med – REPR – Shares Stable on Heels of 2016 Second Quarter Results
Shares of Repro Med (OOTC:REPR) are little changed following the company's 2016 second quarter results. We view this as an encouraging [...]
FDA Warning Letter Could Make This Stock Double
One of the best performing stocks in our portfolio over the last couple years just gave away 50% of its [...]